AA
PDSB icon

ALPS Advisors’s PDS Biotechnology PDSB Stock Holding History

ALPS Advisors’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,822
Closed -$115K – 1002
2023
Q3 		$115K Buy
22,822
+164
+0.7% +$898 ﹤0.01% 967
2023
Q2 		$114K Buy
22,658
+3,880
+21% +$25.4K ﹤0.01% 987
2023
Q1 		$115K Sell
18,778
-589
-3% -$4.82K ﹤0.01% 998
2022
Q4 		$256K Buy
+19,367
New +$137K ﹤0.01% 955
2022
Q2 		– Sell
-29,221
Closed -$181K – 1078
2022
Q1 		$181K Sell
29,221
-3,685
-11% -$22.9K ﹤0.01% 808
2021
Q4 		$267K Buy
+32,906
New +$354K ﹤0.01% 851

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ALPS Advisors's PDSB Position: Q4 2023 in Review

ALPS Advisors sold out of PDS Biotechnology (PDSB) in Q4 2023, closing a stake of 22,822 shares — an estimated $115K sold.

ALPS Advisors first reported a position in PDSB in Q4 2021 and held it in 6 quarters. The position peaked at $267K in Q4 2021. 77 funds tracked by Wall St. Rank hold PDSB as of Q4 2023.

  • ALPS Advisors reported no remaining PDS Biotechnology position as of Q4 2023 after selling out during the quarter.
  • ALPS Advisors sold 22,822 PDS Biotechnology shares in Q4 2023, an estimated $115K.
  • ALPS Advisors first reported a position in PDS Biotechnology in Q4 2021 and held it in 6 quarters.
  • ALPS Advisors's PDS Biotechnology position peaked at $267K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2023.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.